Ventus completes US$100 million in Series B financing, and Academician Wu Hao serves as Chairman of the Scientific Advisory Committee
On April 8, 2021, Waltham, Massachusetts and Montreal, the biotechnology company Ventus Therapeutics, Inc. announced the completion of a US$100 million Series B financing. The company uses drug design based on rational structure...
